Research theme

Experimental & Regenerative Medicine

Experimental & Regenerative Medicine

Experimental and regenerative medicine is the study of the mechanistic foundations of pathologies and the development of new therapies based on tissue regeneration, cell therapy, and pharmacology. With that goal, teams involved with this field have developed unique models for target human pathologies, as well as patient cohorts, for testing innovative therapies. 27 teams in the community are mainly present in 9 laboratories: (BC2M, DMEM, EuromovDMH, IGF, IGH, INM, IRMB, MMDN, PhyMedExp).

Excellence in the experimental and regenerative medicine community is recognized by National BioHealth Infrastructure certification for E-Cell France, which provides services covering all phases of cell therapy projects. In addition, the RegenHab Hospital- University Federation (FHU) is certified by Aviesan.

RegenHab FHU is a clinical, biology, and technology consortium that comprises stem cell biologists, physiologists, roboticists, complex movement imaging specialists, and clinical practitioners in rheumatology, muscular diseases, anesthesia-reanimation, and rehabilitation. The consortium develops new therapeutic approaches to help restore movement for patients suffering from diseases in which musculoskeletal tissue function is altered.